Alan Richens
- Psychiatry and Mental health top 1%
- Epilepsy research and treatment 27
-
- Pharmacological Effects and Toxicity Studies 26
- Pharmaceutical studies and practices 13
-
- Neuroscience and Neuropharmacology Research 8
- Toxicology top 5%
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 6
-
- Drug Transport and Resistance Mechanisms 5
-
- Pharmaceutical Economics and Policy 3
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- Millie BarrettMartin J. BrodieA. GubermanFrank BesagRobert S. SternJoseph M. DooleyMichael DuchownyJohn M. Pellock
- Cited by
- Psychiatry and Mental healthPediatrics, Perinatology and Child HealthCellular and Molecular Neuroscience
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Alan Richens
56 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Psychiatry and Mental health 1.1k
- Pediatrics, Perinatology and Child Health 1.2k
- Cellular and Molecular Neuroscience 387
- Toxicology 72
- Clinical Biochemistry 118
Countries citing papers authored by Alan Richens
This map shows the geographic impact of Alan Richens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Richens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Richens more than expected).
Fields of papers citing papers by Alan Richens
This network shows the impact of papers produced by Alan Richens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Richens. The network helps show where Alan Richens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Richens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 81 | |
| 2 | 2002 | 39 | |
| 3 | 2001 | 26 | |
| 4 | 2001 | 3 | |
| 5 | 1999 | 253 | |
| 6 | 1997 | 11 | |
| 7 | 1997 | 16 | |
| 8 | 1997 | 8 | |
| 9 | 1997 | 14 | |
| 10 | 1996 | 18 | |
| 11 | 1996 | 9 | |
| 12 | 1995 | 13 | |
| 13 | 1994 | 10 | |
| 14 | 1994 | 76 | |
| 15 | 1994 | 5 | |
| 16 | 1991 | 31 | |
| 17 | 1985 | 65 | |
| 18 | Standard units for expressing drug concentrations in biological fluids | 1983 | 1 |
| 19 | 1982 | 50 | |
| 20 | Variability in Human Drug Response | 1974 | 9 |
About Alan Richens
Alan Richens is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Clinical Biochemistry, Cellular and Molecular Neuroscience and Pharmacy, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epilepsy research and treatment (27 papers), Pharmacological Effects and Toxicity Studies (26 papers), Pharmaceutical studies and practices (13 papers), Neuroscience and Neuropharmacology Research (8 papers), Metabolism and Genetic Disorders (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmaceutical Economics and Policy (3 papers) and Drug-Induced Adverse Reactions (2 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Pediatrics, Perinatology and Child Health (1.2k citations), Cellular and Molecular Neuroscience (387 citations), Toxicology (72 citations) and Clinical Biochemistry (118 citations). Alan Richens has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Millie Barrett, Martin J. Brodie, A. Guberman, Frank Besag, Robert S. Stern, Joseph M. Dooley, Michael Duchowny, John M. Pellock, Edwin Trevathan and Emilio Perucca. Their work appears in journals such as Epilepsia, Epilepsy Research, The Lancet, Clinical Pharmacology & Therapeutics and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.